Universal Vision Biotechnology Co Ltd Total Liabilities
Universal Vision Biotechnology Co Ltd total liabilities. Based on the latest financial reports, Universal Vision Biotechnology Co Ltd (3218) has total liabilities worth NT$1.93 Billion TWD (≈ $60.93 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Universal Vision Biotechnology Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Universal Vision Biotechnology Co Ltd (2003–2025)
Total liabilities of Universal Vision Biotechnology Co Ltd from 2003 to 2025. This chart illustrates how Universal Vision Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Universal Vision Biotechnology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Universal Vision Biotechnology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ind-Swift Laboratories Limited
NSE:INDSWFTLAB
|
India | Rs2.37 Billion |
|
Sidetrade
PA:ALBFR
|
France | €45.89 Million |
|
KRAKacquisition Corp Class A Ordinary Shares
NASDAQ:KRAQ
|
USA | $20.79 Million |
|
Guggenheim Taxable Municipal Managed Duration Trust
NYSE:GBAB
|
USA | $175.71 Million |
|
SPCG Public Company Limited
BK:SPCG
|
Thailand | ฿367.68 Million |
|
Australian Ethical Investment Ltd
AU:AEF
|
Australia | AU$29.18 Million |
|
Net Holding AS
IS:NTHOL
|
Turkey | TL39.93 Billion |
|
Hanwha Corp Preferred
KO:00088K
|
Korea | ₩237.85 Trillion |
Liability Composition Analysis (2003–2025)
This chart breaks down Universal Vision Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Universal Vision Biotechnology Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Universal Vision Biotechnology Co Ltd Total Liabilities Ratios Explained
Universal Vision Biotechnology Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Universal Vision Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Universal Vision Biotechnology Co Ltd (2003–2025)
The table below shows the annual total liabilities of Universal Vision Biotechnology Co Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.93 Billion ≈ $60.93 Million |
-3.64% |
| 2024-12-31 | NT$2.01 Billion ≈ $63.23 Million |
+12.27% |
| 2023-12-31 | NT$1.79 Billion ≈ $56.32 Million |
+6.63% |
| 2022-12-31 | NT$1.68 Billion ≈ $52.82 Million |
+17.96% |
| 2021-12-31 | NT$1.42 Billion ≈ $44.77 Million |
+25.80% |
| 2020-12-31 | NT$1.13 Billion ≈ $35.59 Million |
+18.69% |
| 2019-12-31 | NT$951.83 Million ≈ $29.99 Million |
+95.08% |
| 2018-12-31 | NT$487.91 Million ≈ $15.37 Million |
+15.73% |
| 2017-12-31 | NT$421.59 Million ≈ $13.28 Million |
-27.67% |
| 2016-12-31 | NT$582.88 Million ≈ $18.36 Million |
-21.24% |
| 2015-12-31 | NT$740.12 Million ≈ $23.32 Million |
+11.80% |
| 2014-12-31 | NT$662.01 Million ≈ $20.86 Million |
+148.08% |
| 2013-12-31 | NT$266.86 Million ≈ $8.41 Million |
+11.96% |
| 2012-12-31 | NT$238.35 Million ≈ $7.51 Million |
-2.63% |
| 2011-12-31 | NT$244.78 Million ≈ $7.71 Million |
-29.49% |
| 2010-12-31 | NT$347.16 Million ≈ $10.94 Million |
-20.51% |
| 2009-12-31 | NT$436.73 Million ≈ $13.76 Million |
-20.71% |
| 2008-12-31 | NT$550.78 Million ≈ $17.35 Million |
+434.95% |
| 2007-12-31 | NT$102.96 Million ≈ $3.24 Million |
+96.08% |
| 2006-12-31 | NT$52.51 Million ≈ $1.65 Million |
-32.51% |
| 2004-12-31 | NT$77.81 Million ≈ $2.45 Million |
+7.74% |
| 2003-12-31 | NT$72.21 Million ≈ $2.28 Million |
-- |
About Universal Vision Biotechnology Co Ltd
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical instruments, eyeglasses, contact lenses, and eyeglass accessories. It is also involved in eyeglasses optometry and dispensing services and leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy analysis, as we… Read more